Mirxes wins China’s approval to launch groundbreaking blood test for gastric cancer


Cancer screening device developer Mirxes Holding has won approval from Beijing to launch a gastric cancer test, the first blood test for the disease in China’s vast oncology diagnostics market.

Its leading product, GastroClear, an in-house-developed non-invasive blood test, was approved by the National Medical Products Administration of China, the Singapore-based micro ribonucleic acid (miRNA) technology firm said in a filing to Hong Kong’s stock exchange on Thursday.

“GastroClear is the world’s first microRNA blood test approved for the early detection of gastric cancer, evaluating gastric cancer risk by detecting 12 gastric cancer-associated miRNA biomarkers,” it said.

“The company will continue to expand its investment in scaling commercialisation in China, including increasing the size of its sales team and enhancing local production capacity.”

GastroClear has been approved for screening of adults aged 45 to 74. Photo: Handout
GastroClear has been approved for screening of adults aged 45 to 74. Photo: Handout

Gastric cancer was the fifth leading cause of cancer deaths in 2023 globally, and ranked fifth in terms of global incidences that totalled around 1 million among all new cancer cases reported that year, according to Frost & Sullivan.

The combined gastric cancer screening market in China, Japan, Southeast Asia and the US grew by an average annual rate of 4.1 per cent to US$15.2 billion from 2019 to 2023, and was forecast to expand to US$25.4 billion by 2033, Mirxes’ listing prospectus said, citing the market research firm.
  • Related Posts

    Noel Tata to step down as Voltas Chairman in November after turning 70 – Firstpost

    Tata Group veteran Noel Tata on Tuesday announced that he will step down as the Non-Executive Chairman of Voltas in November after attaining the age of 70, marking another leadership…

    Continue reading
    Central banks eye dollar exit as reserve strategy shifts, gold gains favour: OMFIF survey – Firstpost

    The global reserve landscape is showing signs of a structural shift, with central banks for the first time indicating they are more likely to reduce their exposure to the US…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *